Financhill
Buy
90

NRIX Quote, Financials, Valuation and Earnings

Last price:
$19.60
Seasonality move :
-6.39%
Day range:
$19.02 - $20.07
52-week range:
$8.18 - $22.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
19.27x
P/B ratio:
4.04x
Volume:
2.9M
Avg. volume:
1.8M
1-year change:
-5.37%
Market cap:
$1.5B
Revenue:
$54.5M
EPS (TTM):
-$2.97

Earnings Data

Next earnings date for NRIX
Jan 28
2026
Most recent earnings per share
-$1.03
Missed by $0.18
(Oct 9/2025)
Consensus Estimate
-$0.85
(Oct 9/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NRIX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2026 Q1 $16.7M -- -- -$0.83 --
01/28/2026 Q4 $13.4M -- -- -$0.92 --
10/09/2025 Q3 $16.1M $7.9M -$1.03 -$0.85 -$0.18
07/10/2025 Q2 $17.5M $44.1M -$0.52 -$0.74 $0.23
04/08/2025 Q1 $13M $18.5M -$0.67 -$0.76 $0.09
01/28/2025 Q4 $12.9M $13.3M -$0.75 -$0.67 -$0.08
10/11/2024 Q3 $12.3M $12.6M -$0.67 -$0.68 $0.01
07/11/2024 Q2 $21.8M $12.1M -$0.71 -$0.63 -$0.08
04/10/2024 Q1 $17.1M $16.6M -$0.76 -$0.79 $0.03
02/15/2024 Q4 $34.1M $15.2M -$0.77 -$0.50 -$0.27
10/12/2023 Q3 -- $18.5M -$0.68 -- --
07/13/2023 Q2 -- $30.7M -$0.45 -- --
04/13/2023 Q1 -- $12.7M -$0.75 -- --
02/09/2023 Q4 -- $6.8M -$0.87 -- --
10/06/2022 Q3 -- $10.8M -$0.90 -- --
07/07/2022 Q2 -- $11.4M -$1.01 -- --
04/08/2022 Q1 -- $9.6M -$0.95 -- --
01/27/2022 Q4 -- $7.4M -$0.85 -- --
10/14/2021 Q3 -- $10.3M -$0.65 -- --
07/13/2021 Q2 -- $7.1M -$0.60 -- --
04/13/2021 Q1 -- $5M -$0.63 -- --
02/16/2021 Q4 -- $6.7M -$0.51 -- --
10/14/2020 Q3 -- $4.1M -$1.77 -- --
05/31/2020 Q2 -- $4.2M $0.20 -- --
02/29/2020 Q1 -- $2.9M -$0.96 -- --
11/30/2019 Q4 -- $1.9M -$0.35 -- --
08/31/2019 Q3 -- $10.6M -$0.22 -- --
05/31/2019 Q2 -- $9.4M -$0.08 -- --
02/28/2019 Q1 -- $9.2M -$0.21 -- --

Nurix Therapeutics, Inc. Earnings Questions

  • How Much did Nurix Therapeutics, Inc. Generate in Revenue Last Quarter?

    Nurix Therapeutics, Inc. reported $7.9M worth of top line sales in its most recent quarter.

  • Did Nurix Therapeutics, Inc. Beat Earnings Last Quarter?

    Nurix Therapeutics, Inc. announced earnings per share of -$1.03 which represents a miss of analyst forecast a -$0.85 per share.

  • Is Nurix Therapeutics, Inc. Profitable?

    Nurix Therapeutics, Inc. reported $2.9M that represents $0.03 per share over the last quarter.

  • What is the Analyst Consensus for Nurix Therapeutics, Inc. EPS Next Year?

    Nurix Therapeutics, Inc.'s earnings are forecast to decrease from -$2.88 per share to -$3.11 per share next year representing a decrease of -7.77%.

  • When is Nurix Therapeutics, Inc.'s Earnings Date?

    Nurix Therapeutics, Inc.'s next earnings date is January 28, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JetBlue The Best Airline Stock?
Is JetBlue The Best Airline Stock?

Following a general trend of improvement among airline stocks, shares…

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Stock Ideas

Buy
64
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Sell
50
PLAB alert for Dec 10

Photronics, Inc. [PLAB] is up 45.35% over the past day.

Buy
60
OLMA alert for Dec 10

Olema Pharmaceuticals, Inc. [OLMA] is up 15.35% over the past day.

Buy
84
TSAT alert for Dec 10

Telesat Corp. [TSAT] is up 3.07% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock